On December 27, 2021 (Monday), IFEZ signed a land sale contract with SK Bioscience to build a research institute in Songdo International City. SK Bioscience plans to build a vaccine R&D facility in Sr14 lot (178-3 Songdo-dong / 30,413.8㎡) of Techno Park expansion complex in Songdo International City 7, and its headquarters and research institute will be built together. SK Bioscience is said to have changed the paradigm of the domestic and foreign vaccine market based on its own R&D technology and globally recognized production capabilities, and recently played a decisive role in Korea's leap into the hub of global COVID-19 vaccine production.